Residential College | false |
Status | 已發表Published |
Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor | |
Liu,Jianlin1,2; Adhav,Ragini1,2; Miao,Kai1,2; Su,Sek Man1,2; Mo,Lihua1,2; Chan,Un In1,2; Zhang,Xin1,2; Xu,Jun1,2; Li,Jianjie1,2; Shu,Xiaodong1,2; Zeng,Jianming1,2; Zhang,Xu1,2; Lyu,Xueying1,2; Pardeshi,Lakhansing1,3; Tan,Kaeling1,3; Sun,Heng1,2; Wong,Koon Ho1,3; Deng,Chuxia1,2; Xu,Xiaoling1,2 | |
2020-12-01 | |
Source Publication | Nature Communications |
ISSN | 2041-1723 |
Volume | 11Issue:1 |
Abstract | Single-cell whole-exome sequencing (scWES) is a powerful approach for deciphering intratumor heterogeneity and identifying cancer drivers. So far, however, simultaneous analysis of single nucleotide variants (SNVs) and copy number variations (CNVs) of a single cell has been challenging. By analyzing SNVs and CNVs simultaneously in bulk and single cells of premalignant tissues and tumors from mouse and human BRCA1-associated breast cancers, we discover an evolution process through which the tumors initiate from cells with SNVs affecting driver genes in the premalignant stage and malignantly progress later via CNVs acquired in chromosome regions with cancer driver genes. These events occur randomly and hit many putative cancer drivers besides p53 to generate unique genetic and pathological features for each tumor. Upon this, we finally identify a tumor metastasis suppressor Plekha5, whose deficiency promotes cancer metastasis to the liver and/or lung. |
DOI | 10.1038/s41467-020-18637-9 |
URL | View the original |
Indexed By | SCIE |
Language | 英語English |
WOS Research Area | Science & Technology - Other Topics |
WOS Subject | Multidisciplinary Sciences |
WOS ID | WOS:000573737400007 |
Scopus ID | 2-s2.0-85091658171 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | DEPARTMENT OF BIOMEDICAL SCIENCES Faculty of Health Sciences |
Corresponding Author | Deng,Chuxia; Xu,Xiaoling |
Affiliation | 1.Cancer Centre,Faculty of Health Sciences,University of Macau,Macau,China 2.Centre for Precision Medicine Research and Training,Faculty of Health Sciences,University of Macau,Macau,China 3.Genomics,Bioinformatics & Single Cell Analysis Core,Faculty of Health Sciences,University of Macau,Macau,China |
First Author Affilication | Cancer Centre; Faculty of Health Sciences |
Corresponding Author Affilication | Cancer Centre; Faculty of Health Sciences |
Recommended Citation GB/T 7714 | Liu,Jianlin,Adhav,Ragini,Miao,Kai,et al. Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor[J]. Nature Communications, 2020, 11(1). |
APA | Liu,Jianlin., Adhav,Ragini., Miao,Kai., Su,Sek Man., Mo,Lihua., Chan,Un In., Zhang,Xin., Xu,Jun., Li,Jianjie., Shu,Xiaodong., Zeng,Jianming., Zhang,Xu., Lyu,Xueying., Pardeshi,Lakhansing., Tan,Kaeling., Sun,Heng., Wong,Koon Ho., Deng,Chuxia., & Xu,Xiaoling (2020). Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor. Nature Communications, 11(1). |
MLA | Liu,Jianlin,et al."Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor".Nature Communications 11.1(2020). |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment